These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 36800517

  • 1. Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry.
    Breysem L, De Keyzer F, Schellekens P, Dachy A, De Rechter S, Janssens P, Vennekens R, Bammens B, Irazabal MV, Van Ongeval C, Harris PC, Mekahli D, CRISP Consortium.
    Clin J Am Soc Nephrol; 2023 May 01; 18(5):581-591. PubMed ID: 36800517
    [Abstract] [Full Text] [Related]

  • 2. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
    Higashihara E, Yamamoto K, Kaname S, Okegawa T, Tanbo M, Yamaguchi T, Shigemori K, Miyazaki I, Yokoyama K, Nutahara K.
    Clin Exp Nephrol; 2019 Jan 01; 23(1):100-111. PubMed ID: 30097754
    [Abstract] [Full Text] [Related]

  • 3. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
    Bhutani H, Smith V, Rahbari-Oskoui F, Mittal A, Grantham JJ, Torres VE, Mrug M, Bae KT, Wu Z, Ge Y, Landslittel D, Gibbs P, O'Neill WC, Chapman AB, CRISP Investigators.
    Kidney Int; 2015 Jul 01; 88(1):146-51. PubMed ID: 25830764
    [Abstract] [Full Text] [Related]

  • 4. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Kidney Int; 2018 Mar 01; 93(3):691-699. PubMed ID: 29290310
    [Abstract] [Full Text] [Related]

  • 5. Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.
    Akbari P, Nasri F, Deng SX, Khowaja S, Lee SH, Warnica W, Lu H, Rattansingh A, Atri M, Khalili K, York P.
    Clin J Am Soc Nephrol; 2022 Jun 01; 17(6):827-834. PubMed ID: 35383043
    [Abstract] [Full Text] [Related]

  • 6. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bae KT, Zhou W, Shen C, Landsittel DP, Wu Z, Tao C, Chapman AB, Torres VE, Yu ASL, Mrug M, Bennett WM, Harris PC, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Clin J Am Soc Nephrol; 2019 Jun 07; 14(6):823-833. PubMed ID: 31088850
    [Abstract] [Full Text] [Related]

  • 7. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
    Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, HALT PKD and CRISP Study Investigators, Harris PC.
    JCI Insight; 2020 Aug 06; 5(15):. PubMed ID: 32634120
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
    Bais T, Geertsema P, Knol MGE, van Gastel MDA, de Haas RJ, Meijer E, Gansevoort RT, DIPAK Consortium.
    Clin J Am Soc Nephrol; 2024 May 01; 19(5):591-601. PubMed ID: 38407866
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.
    Higashihara E, Horie S, Muto S, Kawano H, Tambo M, Yamaguchi T, Taguchi S, Kaname S, Yokoyama K, Yoshioka T, Furukawa T, Fukuhara H.
    Am J Nephrol; 2020 May 01; 51(11):881-890. PubMed ID: 33227802
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.
    Heida JE, Gansevoort RT, Messchendorp AL, Meijer E, Casteleijn NF, Boertien WE, Zittema D, DIPAK Consortium.
    Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):204-212. PubMed ID: 33504546
    [Abstract] [Full Text] [Related]

  • 16. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
    Siedek F, Grundmann F, Weiss K, Pinto Dos Santos D, Arjune S, Haneder S, Persigehl T, Müller RU, Baessler B.
    Invest Radiol; 2020 Apr 08; 55(4):217-225. PubMed ID: 31876626
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.
    Breysem L, De Rechter S, De Keyzer F, Smet MH, Bammens B, Van Dyck M, Hofmans M, Oyen R, Levtchenko E, Mekahli D.
    Pediatr Nephrol; 2018 May 08; 33(5):827-835. PubMed ID: 29306987
    [Abstract] [Full Text] [Related]

  • 20. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
    Cornec-Le Gall E, Blais JD, Irazabal MV, Devuyst O, Gansevoort RT, Perrone RD, Chapman AB, Czerwiec FS, Ouyang J, Heyer CM, Senum SR, Le Meur Y, Torres VE, Harris PC.
    Nephrol Dial Transplant; 2018 Apr 01; 33(4):645-652. PubMed ID: 28992127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.